Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Epalrestat
Sponsor: Sun Yat-sen University